FDA Orange Book · active-ingredient family
Metronidazole
Metronidazole: 29 brands, 62 generics; first approved Mar 04, 1982; generic available.
Generic availableHas discontinued products
Generic status & protection
Generic available: 62 ANDA applications approved.
Earliest patent expiry
Brands (NDA)
29
Generics (ANDA)
62
Listed patents
9
Next patent expiry
Feb 02, 2028
in 1 yr 4 mo
Brand (NDA) products
Originator applications
- SAPTALIS PHARMSNDA 2167552023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/5ML SUSPENSION ORAL Rx — - ALEMBIC THERAPNDA 2052232014
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.3% GEL VAGINAL Rx — - GALDERMA LABS LPNDA 0217892005
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1% GEL TOPICAL Rx AB - GALDERMA LABS LPNDA 0209011998
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% LOTION TOPICAL Rx AB - FLAGYL ERRLDPFIZERNDA 0208681997
Approved strengths under this FDA application. Strength Dosage form Route Status TE 750MG TABLET, EXTENDED RELEASE ORAL Discontinued — - BAUSCHNDA 0207431997
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1% CREAM TOPICAL Rx — - METROCREAMRLDGALDERMA LABS LPNDA 0205311995
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% CREAM TOPICAL Rx AB - PFIZERNDA 0203341995
Approved strengths under this FDA application. Strength Dosage form Route Status TE 375MG CAPSULE ORAL Rx AB - BAUSCHNDA 0202081992
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Discontinued — - METROGELRLDGALDERMA LABS LPNDA 0197371988
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL TOPICAL Discontinued — - HOSPIRANDA 0188901983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Rx AP - B BRAUNNDA 0189001983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - BAXTER HLTHCARENDA 018657—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Rx AP - FLAGYLRLDPFIZERNDA 012623—2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - TEVA PHARMSNDA 0218062005
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Rx BX - METRONIDAZOLELNKNDA 0190291984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - METRONIDAZOLEHIKMANDA 0189071984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLEABBOTTNDA 0188891983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLECHARTWELL MOLECULESNDA 0188451983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - METRONIDAZOLECHARTWELL MOLECULESNDA 0189301983
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - ORTHO MCNEIL PHARMNDA 01887119832 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - METRONIDAZOLEMUTUAL PHARMNDA 01881819832 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - METRONIDAZOLEFOSUN PHARMANDA 01874019822 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - METRONIDAZOLEWATSON LABSNDA 01859919822 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - METRONIDAZOLEWATSON LABSNDA 01876419822 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - B BRAUNNDA 0186741982
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLEFOSUN PHARMANDA 01862019822 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - PFIZERNDA 018353—
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLEIVAX SUB TEVA PHARMSNDA 018517—2 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued —
Generic (ANDA) products (62)
Abbreviated applications
- METRONIDAZOLEZYDUS LIFESCIENCESANDA 2200952026
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL TOPICAL Rx AB - METRONIDAZOLEAUROBINDO PHARMA LTDANDA 2192952025
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% CREAM TOPICAL Rx AB - METRONIDAZOLESCIEGEN PHARMSANDA 2167502024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Rx AB - METRONIDAZOLEINNOGENIXANDA 07077220243 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB 125MG TABLET ORAL Rx — - METRONIDAZOLEAUROBINDO PHARMA LTDANDA 2189412024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1% GEL TOPICAL Rx AB - METRONIDAZOLEENCUBEANDA 2167952024
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1.3% GEL VAGINAL Discontinued — - METRONIDAZOLECOSETTE PHARMS NCANDA 2163232023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Rx AB - METRONIDAZOLERSENCUBEANDA 2156102023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Rx AB - AMNEALANDA 2176652023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Rx AP - METRONIDAZOLEZYDUS LIFESCIENCESANDA 2171282023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% CREAM TOPICAL Rx BX - METRONIDAZOLECOSETTE PHARMS NCANDA 2166922023
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1% GEL TOPICAL Rx AB - METRONIDAZOLEGLENMARK PHARMS LTDANDA 2157942022
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Rx AB - METRONIDAZOLESOLARIS PHARMA CORPANDA 2136482021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Rx AB - METRONIDAZOLEALEMBICANDA 2126462021
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1% GEL TOPICAL Rx AB - GLANDANDA 2124352020
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Rx AP - METRONIDAZOLEPADAGIS ISRAELANDA 2117862019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Rx AB - INFORLIFEANDA 2061912019
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Rx AP - METRONIDAZOLECADILA PHARMS LTDANDA 20979420172 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - METRONIDAZOLELUPINANDA 20909620172 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - METRONIDAZOLEALEMBICANDA 20868120172 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - RISINGANDA 2055312017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLETAROANDA 2046512017
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1% GEL TOPICAL Rx AB - METRONIDAZOLECADILAANDA 20656020162 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - METRONIDAZOLENOVITIUM PHARMAANDA 20816220162 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - METRONIDAZOLEFLAMINGO PHARMSANDA 20730920162 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - METRONIDAZOLESOMERSET THERAPS LLCANDA 20524520152 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - METRONIDAZOLEAUROBINDO PHARMA LTDANDA 20397420152 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - METRONIDAZOLEUNICHEMANDA 20345820142 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - METRONIDAZOLECHARTWELL RXANDA 0909032011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 1% GEL TOPICAL Discontinued — - METRONIDAZOLERSCOSETTE PHARMS NCANDA 0781782011
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL TOPICAL Rx AB - METRONIDAZOLEALEMBICANDA 0902222010
Approved strengths under this FDA application. Strength Dosage form Route Status TE 750MG TABLET, EXTENDED RELEASE ORAL Discontinued — - METRONIDAZOLEALEMBICANDA 0790652009
Approved strengths under this FDA application. Strength Dosage form Route Status TE 375MG CAPSULE ORAL Rx AB - METRONIDAZOLEALEMBIC PHARMS LTDANDA 07906720092 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB 500MG TABLET ORAL Rx AB - BAXTER HLTHCARE CORPANDA 0780842008
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLECOSETTE PHARMS NCANDA 0775492007
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% CREAM TOPICAL Rx AB - METRONIDAZOLEENCUBEANDA 0772642006
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL VAGINAL Discontinued — - METRONIDAZOLETAROANDA 0778192006
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL TOPICAL Rx AB - METRONIDAZOLEENCUBEANDA 0775472006
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL TOPICAL Rx AB - METRONIDAZOLEFOUGERA PHARMSANDA 0770182006
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% GEL TOPICAL Rx AB - METRONIDAZOLEFOUGERA PHARMSANDA 0771972006
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% LOTION TOPICAL Rx AB - METRONIDAZOLERSFOUGERA PHARMSANDA 0764082004
Approved strengths under this FDA application. Strength Dosage form Route Status TE 0.75% CREAM TOPICAL Rx AB - METRONIDAZOLECHARTWELL RXANDA 0765222004
Approved strengths under this FDA application. Strength Dosage form Route Status TE 375MG CAPSULE ORAL Rx AB - METRONIDAZOLEABLEANDA 0765052003
Approved strengths under this FDA application. Strength Dosage form Route Status TE 375MG CAPSULE ORAL Discontinued — - METRONIDAZOLEABLEANDA 07651920032 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - METRONIDAZOLEABLEANDA 0764622003
Approved strengths under this FDA application. Strength Dosage form Route Status TE 750MG TABLET, EXTENDED RELEASE ORAL Discontinued — - LABS AFANDA 07452319962 strengths
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — 500MG TABLET ORAL Discontinued — - SAVAGE LABSANDA 0707311987
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - METRONIDAZOLEWATSON LABSANDA 0701701986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLEHALSEYANDA 0705931986
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - METRONIDAZOLEINTL MEDICATIONANDA 0700041985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLEHALSEYANDA 0700211985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - SAVAGE LABSANDA 0700291985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - METRONIDAZOLEWATSON LABS INCANDA 0700441985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - METRONIDAZOLESTRIDES PHARMAANDA 0700401985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - METRONIDAZOLESTRIDES PHARMAANDA 0700391985
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - METRONIDAZOLEWATSON LABSANDA 0700421984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLEWATSON LABSANDA 0700351984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB - METRONIDAZOLESUPERPHARMANDA 0700081984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Discontinued — - METRONIDAZOLESUPERPHARMANDA 0700091984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Discontinued — - METRONIDAZOLEPLIVAANDA 0700331984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG TABLET ORAL Rx AB - METRONIDAZOLEABRAXIS PHARMANDA 0700711984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 500MG/100ML INJECTABLE INJECTION Discontinued — - METRONIDAZOLETEVA PHARMS USAANDA 0700271984
Approved strengths under this FDA application. Strength Dosage form Route Status TE 250MG TABLET ORAL Rx AB
Patent & exclusivity timeline
Protection horizon
Patent expiryExclusivity endToday
Listed patents
Orange Book patent file
| Patent | Expires | In | Type |
|---|---|---|---|
| 8877792 | in 1 yr 4 mo | Product | |
| 7893097 | in 1 yr 5 mo | Product | |
| 8658678 | in 1 yr 9 mo | U-1682 | |
| 9198858 | in 5 yr 10 mo | U-1664 | |
| 8946276 | in 5 yr 10 mo | U-1664 | |
| 10238634 | in 5 yr 10 mo | Product | |
| 10596155 | in 5 yr 10 mo | Product | |
| 12257236 | in 12 yr 5 mo | ProductU-3169 | |
| 11541035 | in 13 yr 2 mo | Product |
Approval history
FDA approval span
First approval
45 yr 3 mo ago
Most recent approval
8 mo ago
Approvals span 1982–2026 across 91 FDA applications.
Brand (NDA) 2932%
Generic (ANDA) 6268%
Metronidazole: frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.
Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Related FDA reference tools
- FDA Purple BookLicensed biologics, biosimilars, interchangeables, BLA records, and exclusivity dates.
- FDA BiosimilarsFDA-approved biosimilars and interchangeable biosimilars, by reference product.
- 510(k) Predicate DatabaseSearch FDA 510(k) clearances and map predicate-device lineage.
- FDA 483 DatabaseFDA Form 483 observations and inspection records by firm, date, and citation.

